Clinical trial
Pregabalin Open-Label Extension Trial in Patients With Partial Seizures
NCT00143143 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00143143 |
|---|---|
| Title | Pregabalin Open-Label Extension Trial in Patients With Partial Seizures |
| Official title | Pregabalin BID Open-Label Add-On Trial: A Follow-Up Study To Determine Long-Term Safety and Efficacy in Patients With Partial Seizures |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Epilepsies, Partial, Epilepsy, Complex Partial |
| Intervention type | Drug |
| Interventions | Pregabalin |
| Enrollment | 300 |
| Start date | Sep 1, 2001 |
| Completion | Feb 1, 2006 |
| First posted | Sep 2, 2005 |
| Last update posted | Jul 24, 2006 |
| Countries | Austria, Canada, France, Germany, Italy, Lithuania, Spain, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: